Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
We are a clinicalstage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody therapeutics to treat severe and lifethreatening diseases with unmet medical needs. We use our proprietary XmAb® technology platform to create nextgeneration antibody product candidates designed to treat autoimmune and allergic diseases, cancer and other conditions. In contrast to conventional approaches to antibody design, which focus on the portion of antibodies that interact with target antigens, we focus on the portion of the antibody that interacts with multiple segments of the immune system and controls antibody structure. This portion, referred to as the Fc domain, is constant and interchangeable among antibodies. Our engineered Fc domains, the XmAb technology, can be readily substituted for natural Fc domains. ... More ...
Where does XNCR fit in the risk graph?
|Annual EPS Est:||$-0.45|
|Quarterly EPS Est:||-0.28|